First Patients Treated in XLRP Gene Therapy Trial
Tuesday, September 17 2024 | 14 h 31 min | Vision Science
Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked...
Read More
Lessons From a Superfield Lens
Wednesday, March 20 2024 | 07 h 03 min | Vision Science
By Dr Jenny Lee, OD Aperture Contest Winner Aperture is the publication of the Canadian Association of Optometry Students Reprinted with...
Read More
Stargardt Disease
Thursday, January 18 2024 | 07 h 28 min | Vision Science
Stargardt disease is a rare genetic eye disease that happens when fatty material builds up on the macula Vision loss usually starts in...
Read More Cone-Rod Dystrophy
Wednesday, November 29 2023 | 08 h 21 min | Vision Science
A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa Beacon...
Read More
Clinical Trial Launched to Test New Drug for AMD and DME
Wednesday, November 15 2023 | 13 h 50 min | Vision Science
Fighting Blindness Canada funded researcher Dr Sachdev Sidhu (University of Waterloo) has developed a novel antibody therapy that will now be tested...
Read More
